Bioinova, a.s.

21. 02. 2022

Bioinova develops advanced therapy medicinal products (ATMPs) based on stem and other cells obtained and cultured from bone marrow as well as adipose and other tissues. Bioinova is a certified producer of ATMPs and evaluates the developed products in preclinical studies and own clinical trials.

Moreover, combinations of cells with commercially available as well as own biomaterials (including nanomaterials) are evaluated further enhance the efficacy of the ATMPs and opening novel avenues for regenerative medicine and tissue engineering.

The priority of the company is to provide the patients with innovative, safe, efficient and affordable therapeutic methods in various areas of regenerative medicine. To achieve that, great ideas with high-tech equipment as well as hard work and strong partners are combined. Bioinova has established numerous scientific and industrial collaborations with leading academic institutions, hospitals and high-tech companies in the Czech Republic as well as abroad in terms of biomedical research, translational medicine and clinical practice.

Full name of organization (team):

Bioinova, a.s.


Czech Republic

Type of organization:


Full mailing address of organization: 

Videnska 1083, 142 20 Prague 4, Czech Republic


Number of people in the team:


Contact person:

Peter Bauer, M.D., Ph.D.



Institutional email;